Bicara Therapeutics Inc. Common Stock Long-term Investment Intensity

Latest as of September 2025: 27.6%

Bicara Therapeutics Inc. Common Stock long-term investment intensity. Bicara Therapeutics Inc. Common Stock (BCAX) has a Long-term Investment Intensity of 27.6% as of September 2025. Long-term investments of $117.42 Million represent 27.6% of total assets of $424.69 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read BCAX current and long-term liabilities for a breakdown of total debt and financial obligations.

LT Investment Intensity

27.6%
LT Investments / Total Assets

Long-term Investments

$117.42 Million
USD

Total Assets

$424.69 Million
USD

Country

USA
NASDAQ

Bicara Therapeutics Inc. Common Stock Long-term Investment Intensity by Year (None–None)

Bicara Therapeutics Inc. Common Stock long-term investment intensity by year from None to None. The table below presents the year-by-year Long-term Investment Intensity for Bicara Therapeutics Inc. Common Stock from None to None, covering 0 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Bicara Therapeutics Inc. Common Stock assets under control.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
pp = percentage points